Keynote Lectures

The ESP/IAP Scientific Committee has selected the following world-renowned experts to share their research with the pathology community:

Sunday, 6 December 2020

10:45 - 11:15
A journey in diagnostic onco-pathology of lung cancer
Keith Kerr, United Kingdom

Keith Kerr
About Keith Kerr

Further information will soon be published.

15:45 - 16:15
Fake news in scientific research
John Ioannidis, USA

John Ioannidis
About John Ioannidis

John P.A. Ioannidis, MD, DSc is Professor of Medicine, Professor of Epidemiology and Population Health, and Professor (by courtesy) of Biomedical Data Science at the School of Medicine, Professor (by courtesy) of Statistics at the School of Humanities and Sciences, and co-Director of the Meta-Research Innovation Center at Stanford (METRICS) at Stanford University. 

He is the recipient of many awards and honorary doctorates, and he is a member of many academies and honorific societies in the USA and Europe. He has delivered over 600 invited and honorary lectures. 

The PLoS Medicine paper on “Why most published research findings are false” has been the most-accessed article in the history of Public Library of Science (>3 million hits). He is among the 10 scientists with the highest current citation rate in the world (more than 5,000 new citations per month per Google Scholar). 

Monday, 7 December 2020

10:45 - 11:15 
ESP Symeonidis Lecture 
Do we need pathologists for gastric cancer diagnosis?
Fátima Carneiro, Portugal

Fátima Carneiro
About Fátima Carneiro

Fátima Carneiro, MD, PhD, is Professor of Pathology (Medical Faculty of the University of Porto), Head of Department of Anatomic Pathology (Centro Hospitalar Universitário São João) and Senior Researcher at Ipatimup/i3S. 

She was President of the European Society of Pathology (ESP) (2011-2013) and is currently a member of the scientific committee for the annual ESP Congresses. She is Coordinator of the Portuguese Network of Tumour Banks, council member of the International Gastric Cancer Association (IGCA), member of the International Gastric Cancer Linkage Consortium (IGCLC), board member of the European Academy of Cancer Sciences (EACS) and President of the Portuguese Academy of Medicine. 
She was delegate of Portugal to the Committee for the FP7 specific programme “Cooperation” (2009-2013). Currently, she member of the Mission Assembly for Cancer for the next EU research and innovation framework programme (Horizon Europe) and is member of the Scientific Advisory Board of the ERA-NET on Translational Cancer Research (TRANSCAN). 

She was awarded by the Portuguese Foundation for Science and Technology “for an outstanding curriculum” (2005) and received the Order of “Infante D. Henrique”, Grade Grand Officer, a decoration given by the President of Republic (Portugal) "for outstanding services to science" (2006). She was nominated as “The most influential pathologist in the world" in 2018 (The Pathologist Power List 2018). 

She is (co)author of more than 400 peer-reviewed publications (“h factor”: 69-SCOPUS) and 36 book chapters. She was Co-Editor of the WHO Blue Book on “Tumours of the Digestive System” (4th Edition) and, currently, is a standing member of the WHO Blue Books Editorial Board for the 5th edition of the WHO Classification of Tumours series (2018–2020). Her research is directed towards the understanding of the etiopathogenesis and molecular pathology of gastric carcinoma, sporadic and hereditary.

16:15 - 16:45
Using tissues and biomarkers well
Carolyn Compton, USA

Carolyn Compton
About Carolyn Compton

Carolyn Compton, MD, PhD, is an academic pathologist specializing in gastrointestinal disease and is board certified in both anatomic and clinical pathology. She received her MD and PhD degrees at the Harvard. She is a Professor of Life Sciences at Arizona State University (ASU), a Professor of Laboratory Medicine and Pathology at the Mayo Clinic School of Medicine, and an adjunct Professor of Pathology at the Johns Hopkins Medical School. 

She is the Chief Medical Officer of the National Biomarker Development Alliance, and an Affiliated Scholar at the ASU Center for Healthcare Delivery and Policy. She is the Medical Director of the ASU Biodesign Clinical Testing Laboratory. 
Dr. Compton is a former Professor of Pathology at Harvard Medical School, Chief of Gastrointestinal Pathology at Massachusetts General Hospital and Pathologist-in-Chief of the Boston Shriners Children’s Hospital. 
She served as the Chair of the Pathology Committee of Cancer and Leukemia Group B Clinical Trials Group for 15 years. 
She is the past Director of the Office of Biorepositories and Biospecimen Research and the Director of the Innovative Molecular Analysis Technologies program at the National Cancer Institute. 
Dr. Compton was the Strathcona Professor and Chair of the Department of Pathology at McGill University and Pathologist-in-Chief of the McGill University Health Center. 
She is a past Chair of the Cancer Committee of the College of American Pathologists and past Chair of the American Joint Committee on Cancer (AJCC). 

Currently, she is the Chair of the Precision Medicine Core of the AJCC and the Chair of the Preanalytics for Precision Medicine Project Team of the College of American Pathologists. She serves on the United States Technical Advisory Group to the International Standards Organization and the Scientific and the Scientific and Ethical Advisory Board of BBMRI of the European Research Infrastructure Consortium. 

This year, her latest textbook entitled Cancer, The Enemy from Within was published, and she was a recipient of the Team Science Award of the American Association of Cancer Research for her work on The Cancer Genome Atlas (TCGA) project. She has authored more than 500 scientific manuscripts, review articles, books, chapters, and abstracts.

All times are in GMT.